Indaptus Therapeutics, Inc. (INDP) Tops Q3 EPS by 5c

Indaptus Therapeutics, Inc. (NASDAQ: INDP) reported Q3 EPS of ($0.47), $0.05 better than the analyst estimate of ($0.52).

For earnings history and earnings-related data on Indaptus Therapeutics, Inc. (INDP) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• Is Treasury selloff a major issue for stock market bulls?
• The LGL Group (LGL) Misses Q2 EPS by 8c